Vanda’s Nereus: Motion Sickness Drug Lacked Adequate Nonclinical Cumulative Exposure Data

Drug Review Profile: Nereus
The FDA approved Nereus for motion-induced vomiting. (Citeline/Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Review Profiles

More from United States